Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research Phase I Fast-Track grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay that can simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.
http://ift.tt/QAPf6y
http://ift.tt/QAPf6y
No comments:
Post a Comment